Coronary artery diseases. Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects have coronary artery disease (with the condition of at least 50% narrowing of at least two main coronary arteries), which has been confirmed by cardiologists based on examinations, complete blood tests, echocardiography, exercise stress test and angiography.
Exclusion criteria
Exclusion criteria: using of drugs or other antioxidant supplements other than the supplements considered in this research
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Matrix Metalloproteinases 1? 2? 3 and 9. Timepoint: beginning and end of the eight-week experimental period. Method of measurement: Sampling of venous blood.;Tissue inhibitor of Matrix Metalloproteinases 1. Timepoint: beginning and end of the eight-week experimental period. Method of measurement: Sampling of venous blood. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate of subjects during exercise training. Timepoint: At the beginning, during and at the end of each exercise training session. Method of measurement: Using the cardiac monitoring device with the subjects.;Systolic and diastolic blood pressure of subjects during exercise. Timepoint: At the beginning and at the end of each exercise training session. Method of measurement: Using an analog blood pressure monitor. | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University, Zanjan Branch